Cost comparison of intra-detrusor injection of botulinum toxin versus augmentation cystoplasty for refractory neurogenic detrusor overactivity in children

Affiliations

¹ Division of Pediatric Urology, Texas Children's Hospital, Houston, TX, USA.
² Institute for Pediatric Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA.
³ Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.
⁴ Anne Arundel Urology, Annapolis, MD, USA.
⁵ Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
⁶ Institute for Pediatric Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA. Electronic address: apa9010@med.cornell.edu.

Comment

Soo Jeong Kim et al. J Pediatr Urol. 2022 Jun.

. 2022 Jun;18(3):321-322.

doi: 10.1016/j.jpurol.2022.02.020. Epub 2022 Mar 8.

¹ Division of Pediatric Urology, Texas Children's Hospital, Houston, TX, USA.
² Institute for Pediatric Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA.
³ Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.
⁴ Anne Arundel Urology, Annapolis, MD, USA.
⁵ Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
⁶ Institute for Pediatric Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA. Electronic address: apa9010@med.cornell.edu.

No abstract available

Comment on